These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21441960)

  • 41. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
    Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
    Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis.
    Tollemar V; Tudzarovski N; Warfvinge G; Yarom N; Remberger M; Heymann R; Garming Legert K; Sugars RV
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1971-1979. PubMed ID: 32659433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
    Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
    Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
    Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Reddy P; Johnson K; Uberti JP; Reynolds C; Silver S; Ayash L; Braun TM; Ratanatharathorn V
    Bone Marrow Transplant; 2006 Sep; 38(5):351-7. PubMed ID: 16862167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life associated with acute and chronic graft-versus-host disease.
    Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH
    Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
    Hidaka M; Iwasaki S; Matsui T; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Kiyokawa T; Takahashi M; Saibara T; Onishi S; Kawano F
    Bone Marrow Transplant; 2010 May; 45(5):912-8. PubMed ID: 19802024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
    Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation.
    Kim DH; Sohn SK; Kim JG; Suh JS; Lee KS; Lee KB
    Bone Marrow Transplant; 2004 May; 33(10):1025-30. PubMed ID: 15064689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease.
    Resende RG; de Fátima Correia-Silva J; Arão TC; Brito JA; Bittencourt H; Gomez RS; Abreu MH
    Clin Oral Investig; 2012 Apr; 16(2):565-70. PubMed ID: 21369795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study).
    Rashidi A; Pidala J; Hamilton BK; Pavletic SZ; Kim K; Zevin A; Mays JW; Lee SJ
    Clin Cancer Res; 2024 Sep; 30(18):4240-4250. PubMed ID: 39017661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.